Admera’s Portfolio employs state-of-the-art genomics
technology, allowing for rapid screening of multiple genes
in parallel. All results are delivered in an actionable report,
allowing physicians to provide personalized healthcare to
their patients, based on their unique and specific needs.
Admera’s Product Portfolio
PGxOne™ Plus is a comprehensive pharmacogenomics (PGx) test that includes over 50 genes and 200 variants.